Lee Griffiths is an Associate Partner with more than 20 years of experience spanning global roles across pharmaceutical and consumer healthcare multinationals. He brings deep expertise at the intersection of commercial strategy, emerging science and customer insight, enabling him to guide cross-functional client teams through a broad range of strategic and commercial challenges.
Lee has extensive experience in brand and portfolio strategy across immunology, infectious diseases and oncology, including a wide range of solid tumours. He has worked across the full product development lifecycle, from early asset strategy and clinical development through to launch and mature in-line brand management. His particular passion lies in supporting organisations with early asset and portfolio strategy, drawing on his strong foundation in R&D and innovation.
Lee began his career at AstraZeneca as part of the R&D Graduate Programme, where he supported programmes through Phases I–III in respiratory and cardiovascular disease. He later moved into innovation leadership roles at Reckitt Benckiser, leading innovation initiatives for several major global consumer healthcare brands, including Nurofen, Scholl and Mucinex.
Throughout his career, Lee has combined scientific credibility with strategic commercial thinking, helping clients navigate complex market dynamics, shape impactful brand strategies and unlock growth opportunities across the healthcare landscape.
He describes himself as collaborative, commercially driven and passionate about translating science into meaningful business impact.
